Skip to content

Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery

A Clinical Validation Study of Novel Infrared Fluorescence Rapid Staining Versus Conventional Frozen Section in Intraoperative Diagnosis of Prostate Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07690462
Enrollment
120
Registered
2026-07-08
Start date
2026-07-01
Completion date
2027-12-01
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

This study aims to validate the accuracy of the infrared fluorescence rapid detection technique for the diagnosis of prostate biopsy specimens, and to compare it with intraoperative frozen section and conventional paraffin section (the gold standard), so as to evaluate its feasibility and value in clinical application.

Interventions

None listed

Sponsors

Xiangya Hospital of Central South University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

1. All adult male patients who are scheduled to undergo prostate biopsy at the Department of Urology, Xiangya Hospital due to clinical suspicion (e.g., elevated PSA, abnormal digital rectal examination, or suspicious lesions on imaging). 2. Patients whose cardiac, pulmonary, hepatic, renal, and coagulation functions are essentially normal and who are able to tolerate the biopsy procedure. 3. The patient or their legally authorized representative has signed the written informed consent form.

Exclusion criteria

1. Patients in the acute infection phase or febrile period. 2. Patients with severe bleeding tendency conditions who are unable to undergo biopsy. 3. Patients with any serious concomitant disease that, in the investigator's opinion, may interfere with the study results or increase the patient's risk (e.g., hypertensive crisis; decompensated cardiac insufficiency; severe internal or external hemorrhoids, perianal or rectal lesions, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of prostate biopsy specimensAt baseline (Single visit)To evaluate the diagnostic accuracy of the novel rapid infrared fluorescence staining technique for prostate biopsy specimens, and to compare it with frozen section.

Countries

China

Contacts

CONTACTYi Cai
cai-yi@csu.edu.cn+8613637310713
CONTACTChangchun Lin
lincc0207@163.com+8618808942834

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026